Targeting Acetyl-CoA Carboxylase 1 for Cancer Therapy

Overview

Journal Front Pharmacol

Date 2023 Feb 27

PMID 36843935

Authors

Yong Yu

Qingzhu Nie

Ziyi Wang

Yu Di

Xiaolong Chen

Kaiming Ren

Affiliations

Soon will be listed here.

Abstract

Metabolic adaptation is an emerging hallmark of tumors. fatty acid synthesis is an important metabolic process to produce metabolic intermediates for energy storage, biosynthesis of membrane lipids and generation of signaling molecules. Acetyl-CoA carboxylase 1 (ACC1) is a critical enzyme in the fatty acid synthesis, which carboxylates acetyl-CoA carboxylic acid to form malonyl-CoA. The role of acetyl-CoA carboxylase 1 in fatty acid synthesis makes it a promising therapeutic target for various metabolic diseases such as non-alcoholic fatty liver disease, obesity and diabetes. Tumors have a high energy flow and a strong dependence on fatty acid synthesis. Thus, acetyl-CoA carboxylase inhibition has become a potential choice for anti-tumor therapy. In this review, we first introduced the structure and expression pattern of Acetyl-CoA carboxylase 1. We also discussed the molecular mechanisms of acetyl-CoA carboxylase 1 in the initiation and progression of various cancer types. Furthermore, acetyl-CoA carboxylase1 inhibitors has also been discussed. Collectively, we summarized the interplay between acetyl-CoA carboxylase 1 and tumorigenesis, indicating acetyl-CoA carboxylase 1 as a promising therapeutic target for tumor management.

Citing Articles

Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment.

Yang H, Li J, Niu Y, Zhou T, Zhang P, Liu Y Front Immunol. 2025; 16:1494788.

PMID: 40028341 PMC: 11868052. DOI: 10.3389/fimmu.2025.1494788.

The role of myocardial energy metabolism perturbations in diabetic cardiomyopathy: from the perspective of novel protein post-translational modifications.

Li D, Zhang L, Gong Q, Deng H, Luo C, Zhou T Clin Epigenetics. 2025; 17(1):15.

PMID: 39865334 PMC: 11765930. DOI: 10.1186/s13148-025-01814-2.

Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy.

Li J, Ping P, Li Y, Xu X Chin J Cancer Res. 2025; 36(6):652-668.

PMID: 39802901 PMC: 11724175. DOI: 10.21147/j.issn.1000-9604.2024.06.05.

Metabolic reprogramming in lung cancer and its clinical implication.

Huang Q, Fan L, Gong M, Ren J, Chen C, Xie S Front Pharmacol. 2025; 15:1516650.

PMID: 39744129 PMC: 11688361. DOI: 10.3389/fphar.2024.1516650.

Tumor energy metabolism: implications for therapeutic targets.

Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q Mol Biomed. 2024; 5(1):63.

PMID: 39609317 PMC: 11604893. DOI: 10.1186/s43556-024-00229-4.

References

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Ito H, Nakamae I, Kato J, Yoneda-Kato N . Stabilization of fatty acid synthesis enzyme acetyl-CoA carboxylase 1 suppresses acute myeloid leukemia development. J Clin Invest. 2021; 131(12). PMC: 8203453. DOI: 10.1172/JCI141529. View

Kim C, Addy C, Kusunoki J, Anderson N, Deja S, Fu X . Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation. Cell Metab. 2017; 26(2):394-406.e6. PMC: 5603267. DOI: 10.1016/j.cmet.2017.07.009. View

Hunkeler M, Hagmann A, Stuttfeld E, Chami M, Guri Y, Stahlberg H . Structural basis for regulation of human acetyl-CoA carboxylase. Nature. 2018; 558(7710):470-474. DOI: 10.1038/s41586-018-0201-4. View

Kim K . Regulation of mammalian acetyl-coenzyme A carboxylase. Annu Rev Nutr. 1997; 17:77-99. DOI: 10.1146/annurev.nutr.17.1.77. View

Jiang J, Peng L, Wang K, Huang C . Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code. Antioxid Redox Signal. 2020; 34(13):979-1003. DOI: 10.1089/ars.2020.8123. View

Butler L, Mah C, Machiels J, Vincent A, Irani S, Mutuku S . Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition. Cancer Res. 2021; 81(19):4981-4993. DOI: 10.1158/0008-5472.CAN-20-3863. View

Svensson R, Parker S, Eichner L, Kolar M, Wallace M, Brun S . Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models. Nat Med. 2016; 22(10):1108-1119. PMC: 5053891. DOI: 10.1038/nm.4181. View

Brusselmans K, De Schrijver E, Verhoeven G, Swinnen J . RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res. 2005; 65(15):6719-25. DOI: 10.1158/0008-5472.CAN-05-0571. View

10.

Prada-Arismendy J, Arroyave J, Rothlisberger S . Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2016; 31(1):63-76. DOI: 10.1016/j.blre.2016.08.005. View

11.

Calle R, Amin N, Carvajal-Gonzalez S, Ross T, Bergman A, Aggarwal S . ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials. Nat Med. 2021; 27(10):1836-1848. DOI: 10.1038/s41591-021-01489-1. View

12.

Brownsey R, Boone A, Elliott J, Kulpa J, Lee W . Regulation of acetyl-CoA carboxylase. Biochem Soc Trans. 2006; 34(Pt 2):223-7. DOI: 10.1042/BST20060223. View

13.

Rohrig F, Schulze A . The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016; 16(11):732-749. DOI: 10.1038/nrc.2016.89. View

14.

Chajes V, Cambot M, Moreau K, Lenoir G, Joulin V . Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 2006; 66(10):5287-94. DOI: 10.1158/0008-5472.CAN-05-1489. View

15.

Lally J, Ghoshal S, DePeralta D, Moaven O, Wei L, Masia R . Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma. Cell Metab. 2018; 29(1):174-182.e5. PMC: 6643297. DOI: 10.1016/j.cmet.2018.08.020. View

16.

Kelly K, Reagan W, Sonnenberg G, Clasquin M, Hales K, Asano S . De novo lipogenesis is essential for platelet production in humans. Nat Metab. 2020; 2(10):1163-1178. DOI: 10.1038/s42255-020-00272-9. View

17.

Goedeke L, Bates J, Vatner D, Perry R, Wang T, Ramirez R . Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents. Hepatology. 2018; 68(6):2197-2211. PMC: 6251774. DOI: 10.1002/hep.30097. View

18.

Hunkeler M, Stuttfeld E, Hagmann A, Imseng S, Maier T . The dynamic organization of fungal acetyl-CoA carboxylase. Nat Commun. 2016; 7:11196. PMC: 4833862. DOI: 10.1038/ncomms11196. View

19.

Yoshida K, Asaoka Y, NISHIZUKA Y . Platelet activation by simultaneous actions of diacylglycerol and unsaturated fatty acids. Proc Natl Acad Sci U S A. 1992; 89(14):6443-6. PMC: 49517. DOI: 10.1073/pnas.89.14.6443. View

20.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View